company

KLINIKK OPTIMAL TANANGER AS

4056 TANANGER

Return on Equity
−5,59 %
Current Ratio
1,43
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue8 626 000
Net Income−57 000
Total Assets3 269 000
Total Equity1 020 000
Income (NOK)2022
Revenue8 626 000
Expenditure8 610 000
Operating Profit16 000
Financial Income0
Financial Costs62 000
Financial Balance−62 000
Earnings Before Tax−47 000
Tax10 000
Net Income−57 000
Balance (NOK)2022
Total Fixed Assets57 000
Total Current Assets3 212 000
Total Assets3 269 000
Total Retained Equity990 000
Total Equity1 020 000
Total Long-Term Debt0
Total Current Debt2 249 000
Total Equity and Debt3 269 000
Cash flow (NOK)2022
Sales Income8 626 000
Other Income0
Revenue8 626 000
Cost of Goods Sold6 289 000
Salary Costs658 000
Depreciation63 000
Impairment0
Expenditure8 610 000
Operating Profit16 000
Financial Income0
Financial Costs62 000
Financial Balance−62 000
Dividends0
Net Income−57 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets25 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures32 000
Total Tangible Assets32 000
Total Fiancial Fixed Assets0
Total Fixed Assets57 000
Stock129 000
Total Investments440 000
Cash, Bank1 520 000
Total Current Assets3 212 000
Total Assets3 269 000
Total Equity1 020 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors1 023 000
Unpaid Taxes60 000
Dividends0
Other Current Debt1 155 000
Total Current Debt2 249 000
Total Equity and Debt3 269 000
Financial indicators2022
Return on Equity−5,59 %
Debt-to-Equity Ratio0
Operating Profit Margin0,19 %
Current Ratio1,43
Quick Ratio1,52
Equity Ratio0,31
Gross Profit Margin27,09 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English